blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3141599

EP3141599 - ALLOGENEIC MICROVASCULAR TISSUE FOR SOFT TISSUE TREATMENTS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  27.10.2023
Database last updated on 03.09.2024
FormerThe patent has been granted
Status updated on  18.11.2022
FormerGrant of patent is intended
Status updated on  02.06.2022
FormerExamination is in progress
Status updated on  28.09.2018
FormerRequest for examination was made
Status updated on  10.02.2017
Most recent event   Tooltip24.05.2024Lapse of the patent in a contracting state
New state(s): IT		published on 26.06.2024  [2024/26]
Applicant(s)For all designated states
MicroVascular Tissues, Inc.
6199 Cornerstone Court East
Suite 109
San Diego, California 92121 / US
[2022/46]
Former [2017/11]For all designated states
MicroVascular Tissues, Inc.
100 Cummings Center, Suite 215F
Beverly, MA 01915 / US
Inventor(s)01 / PETERSON, Dale R.
Gilbert, AZ 85297 / US
02 / EMMITT, Richard B.
Oldwick, NJ 08858 / US
 [2022/46]
Former [2017/11]01 / PETERSON, Dale R.
1002 Skylark Drive
LA JOLLA - USA, 92037 / US
02 / EMMITT, Richard B.
PO Box 331
OLDWICK, 08858 / US
Representative(s)Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB
Ganghoferstraße 68 B
80339 München / DE
[2022/51]
Former [2017/11]Lavoix
62, rue de Bonnel
69448 Lyon Cedex 03 / FR
Application number, filing date16195005.017.03.2012
[2017/11]
Priority number, dateUS201161454367P18.03.2011         Original published format: US 201161454367 P
[2017/11]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3141599
Date:15.03.2017
Language:EN
[2017/11]
Type: B1 Patent specification 
No.:EP3141599
Date:21.12.2022
Language:EN
[2022/51]
Search report(s)(Supplementary) European search report - dispatched on:EP27.01.2017
ClassificationIPC:C12N5/00, A61K35/28, C12N5/077
[2017/11]
CPC:
A61L27/3662 (EP,US); A61K35/12 (US); A61K35/28 (EP,US);
A61K35/35 (EP,US); A61L27/3604 (US); A61L27/3625 (EP,US);
A61L27/3683 (EP,US); A61L27/3687 (US); A61L27/3691 (US);
A61L27/3834 (EP,US); A61L27/54 (US); A61L27/56 (US);
C12N5/0653 (EP,US); A61L2300/64 (US); A61L2430/06 (US);
A61L2430/10 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/11]
TitleGerman:ALLOGENES MIKROVASKULÄRES GEWEBE FÜR WEICHGEWEBEBEHANDLUNGEN[2017/11]
English:ALLOGENEIC MICROVASCULAR TISSUE FOR SOFT TISSUE TREATMENTS[2017/11]
French:TISSU MICROVASCULAIRE ALLOGÉNIQUE POUR TRAITEMENTS DE TISSUS MOUS[2017/11]
Examination procedure21.10.2016Examination requested  [2017/11]
21.10.2016Date on which the examining division has become responsible
25.08.2017Amendment by applicant (claims and/or description)
26.09.2018Despatch of a communication from the examining division (Time limit: M06)
09.05.2019Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
08.07.2019Reply to a communication from the examining division
20.02.2020Despatch of a communication from the examining division (Time limit: M04)
23.06.2020Reply to a communication from the examining division
17.12.2020Despatch of a communication from the examining division (Time limit: M06)
28.06.2021Reply to a communication from the examining division
03.06.2022Communication of intention to grant the patent
12.10.2022Fee for grant paid
12.10.2022Fee for publishing/printing paid
12.10.2022Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP12782247.6  / EP2686419
Opposition(s)22.09.2023No opposition filed within time limit [2023/48]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
08.07.2019Request for further processing filed
08.07.2019Full payment received (date of receipt of payment)
Request granted
17.07.2019Decision despatched
Fees paidRenewal fee
21.10.2016Renewal fee patent year 03
21.10.2016Renewal fee patent year 04
21.10.2016Renewal fee patent year 05
27.03.2017Renewal fee patent year 06
27.03.2018Renewal fee patent year 07
27.03.2019Renewal fee patent year 08
27.03.2020Renewal fee patent year 09
29.03.2021Renewal fee patent year 10
28.03.2022Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL21.12.2022
AT21.12.2022
CZ21.12.2022
DK21.12.2022
EE21.12.2022
FI21.12.2022
HR21.12.2022
IT21.12.2022
LT21.12.2022
LV21.12.2022
MC21.12.2022
NL21.12.2022
PL21.12.2022
RO21.12.2022
RS21.12.2022
SI21.12.2022
SK21.12.2022
SM21.12.2022
IE17.03.2023
LU17.03.2023
NO21.03.2023
GR22.03.2023
CH31.03.2023
LI31.03.2023
IS21.04.2023
PT21.04.2023
[2024/26]
Former [2024/11]AL21.12.2022
AT21.12.2022
CZ21.12.2022
DK21.12.2022
EE21.12.2022
FI21.12.2022
HR21.12.2022
LT21.12.2022
LV21.12.2022
MC21.12.2022
NL21.12.2022
PL21.12.2022
RO21.12.2022
RS21.12.2022
SI21.12.2022
SK21.12.2022
SM21.12.2022
IE17.03.2023
LU17.03.2023
NO21.03.2023
GR22.03.2023
CH31.03.2023
LI31.03.2023
IS21.04.2023
PT21.04.2023
Former [2024/09]AL21.12.2022
AT21.12.2022
CZ21.12.2022
DK21.12.2022
EE21.12.2022
FI21.12.2022
HR21.12.2022
LT21.12.2022
LV21.12.2022
MC21.12.2022
NL21.12.2022
PL21.12.2022
RO21.12.2022
RS21.12.2022
SK21.12.2022
SM21.12.2022
IE17.03.2023
LU17.03.2023
NO21.03.2023
GR22.03.2023
CH31.03.2023
LI31.03.2023
IS21.04.2023
PT21.04.2023
Former [2024/08]AL21.12.2022
AT21.12.2022
CZ21.12.2022
DK21.12.2022
EE21.12.2022
FI21.12.2022
HR21.12.2022
LT21.12.2022
LV21.12.2022
MC21.12.2022
NL21.12.2022
PL21.12.2022
RO21.12.2022
RS21.12.2022
SK21.12.2022
SM21.12.2022
IE17.03.2023
LU17.03.2023
NO21.03.2023
GR22.03.2023
IS21.04.2023
PT21.04.2023
Former [2024/02]AL21.12.2022
AT21.12.2022
CZ21.12.2022
DK21.12.2022
EE21.12.2022
FI21.12.2022
HR21.12.2022
LT21.12.2022
LV21.12.2022
MC21.12.2022
NL21.12.2022
PL21.12.2022
RO21.12.2022
RS21.12.2022
SK21.12.2022
SM21.12.2022
LU17.03.2023
NO21.03.2023
GR22.03.2023
IS21.04.2023
PT21.04.2023
Former [2023/48]AL21.12.2022
AT21.12.2022
CZ21.12.2022
DK21.12.2022
EE21.12.2022
FI21.12.2022
HR21.12.2022
LT21.12.2022
LV21.12.2022
MC21.12.2022
NL21.12.2022
PL21.12.2022
RO21.12.2022
RS21.12.2022
SK21.12.2022
SM21.12.2022
NO21.03.2023
GR22.03.2023
IS21.04.2023
PT21.04.2023
Former [2023/46]AL21.12.2022
AT21.12.2022
CZ21.12.2022
DK21.12.2022
EE21.12.2022
FI21.12.2022
HR21.12.2022
LT21.12.2022
LV21.12.2022
NL21.12.2022
PL21.12.2022
RO21.12.2022
RS21.12.2022
SK21.12.2022
SM21.12.2022
NO21.03.2023
GR22.03.2023
IS21.04.2023
PT21.04.2023
Former [2023/39]AL21.12.2022
AT21.12.2022
CZ21.12.2022
EE21.12.2022
FI21.12.2022
HR21.12.2022
LT21.12.2022
LV21.12.2022
NL21.12.2022
PL21.12.2022
RO21.12.2022
RS21.12.2022
SK21.12.2022
SM21.12.2022
NO21.03.2023
GR22.03.2023
IS21.04.2023
PT21.04.2023
Former [2023/38]AL21.12.2022
AT21.12.2022
CZ21.12.2022
EE21.12.2022
FI21.12.2022
HR21.12.2022
LT21.12.2022
LV21.12.2022
NL21.12.2022
PL21.12.2022
RO21.12.2022
RS21.12.2022
SK21.12.2022
SM21.12.2022
NO21.03.2023
GR22.03.2023
PT21.04.2023
Former [2023/37]AL21.12.2022
AT21.12.2022
CZ21.12.2022
EE21.12.2022
FI21.12.2022
HR21.12.2022
LT21.12.2022
LV21.12.2022
NL21.12.2022
RO21.12.2022
RS21.12.2022
SM21.12.2022
NO21.03.2023
GR22.03.2023
PT21.04.2023
Former [2023/35]AT21.12.2022
CZ21.12.2022
EE21.12.2022
FI21.12.2022
HR21.12.2022
LT21.12.2022
LV21.12.2022
NL21.12.2022
RO21.12.2022
RS21.12.2022
SM21.12.2022
NO21.03.2023
GR22.03.2023
PT21.04.2023
Former [2023/34]EE21.12.2022
FI21.12.2022
HR21.12.2022
LT21.12.2022
LV21.12.2022
NL21.12.2022
RS21.12.2022
SM21.12.2022
NO21.03.2023
GR22.03.2023
PT21.04.2023
Former [2023/33]FI21.12.2022
HR21.12.2022
LT21.12.2022
LV21.12.2022
NL21.12.2022
RS21.12.2022
SM21.12.2022
NO21.03.2023
GR22.03.2023
Former [2023/29]FI21.12.2022
HR21.12.2022
LT21.12.2022
LV21.12.2022
NL21.12.2022
RS21.12.2022
NO21.03.2023
GR22.03.2023
Former [2023/27]FI21.12.2022
HR21.12.2022
LT21.12.2022
LV21.12.2022
RS21.12.2022
NO21.03.2023
GR22.03.2023
Former [2023/24]FI21.12.2022
HR21.12.2022
LT21.12.2022
LV21.12.2022
NO21.03.2023
GR22.03.2023
Former [2023/23]FI21.12.2022
LT21.12.2022
LV21.12.2022
NO21.03.2023
GR22.03.2023
Former [2023/22]FI21.12.2022
LT21.12.2022
NO21.03.2023
Former [2023/20]LT21.12.2022
NO21.03.2023
Documents cited:Search[X]EP0668013  (NIPPON TELEGRAPH & TELEPHONE [JP]) [X] 4,5,11,13 * page 5, lines 1-40, 49-51; example 12; claims 1,6 *;
 [Y]WO9726326  (BOEHRINGER MANNHEIM CORP [US]) [Y] 1-15 * page 26, line 11 - page 29, line 12 * * page 29, line 15 - page 31, line 12 * * page 32, lines 18-21 * * page 21, lines 2-8 * * sentence 3; example 6 * * page 40, line 7 *;
 [A]WO2004006961  (BIOSYNTECH CANADA INC [CA], et al) [A] 1-15 * the whole document *;
 [Y]US2006147430  (SAYRE CHAUNCEY B [US], et al) [Y] 1-15* the whole document *;
 [A]US2008033572  (D ANTONIO PAUL [US], et al) [A] 1-15 * the whole document *;
 [Y]WO2009115581  (CRYO SAVE AG [CH], et al) [Y] 1-15 * page 1, lines 18-33 * * page 3, line 18 - page 4, line 8 *;
 [Y]  - YOSHIMURA KOTARO ET AL, "Adipose-derived stem/progenitor cells: roles in adipose tissue remodeling and potential use for soft tissue augmentation", REGENERATIVE MEDICINE, FUTURE MEDICINE LTD, GB, (20090301), vol. 4, no. 2, ISSN 1746-0751, pages 265 - 273, XP009179725 [Y] 1-15 * page 266, column r, paragraph last * * page 270, column l, lines 14-16 * * page 270, paragraph last - column r *

DOI:   http://dx.doi.org/10.2217/17460751.4.2.265
 [Y]  - S. E. HANSON ET AL, "Clinical Applications of Mesenchymal Stem Cells in Soft Tissue Augmentation", AESTHETIC SURGERY JOURNAL, (20101101), vol. 30, no. 6, doi:10.1177/1090820X10386364, ISSN 1090-820X, pages 838 - 842, XP055134783 [Y] 1-15 * page 4, paragraphs 3-5 *

DOI:   http://dx.doi.org/10.1177/1090820X10386364
 [Y]  - HANSON SUMMER E ET AL, "Mesenchymal stem cell therapy for nonhealing cutaneous wounds", PLASTIC AND RECONSTRUCTIVE SURGERY : JOURNAL OF THE AMERICAN SOCIETY OF PLASTIC SURGEONS ; OFFICIAL ORGAN OF THE AMERICAN ASSOCIATION OF PLASTIC SURGEONS ; OFFICIAL ORGAN OF THE AMERICAN SOCIETY OF AESTHETIC PLASTIC SURGERY ; OFFICIAL ORGAN OF THE AM, (20100201), vol. 125, no. 2, ISSN 1529-4242, pages 510 - 516, XP009179681 [Y] 1-15 * pages 511,512,; table 1 *

DOI:   http://dx.doi.org/10.1097/PRS.0b013e3181c722bb
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.